While wrong-site spinal surgeries are rare, the ramifications of a mistake can be devastating for patients, providers and health systems. Rochester, Minn.-based Mayo Clinic is taking systemwide action ...

Similar to nonsurgical treatment, the goal of surgical intervention is to relieve pressure on spinal cord or the nerve roots. Relieving pressure on the nerves will alleviate pain and fatigue ...

Spinal stenosis refers to narrowing of the spinal canal or tunnel that houses the neural elements (nerves) that travel along the spinal column. The narrowing can be central stenosis (referring to the ...

The spinal component of the accessory nerve is made up of roots from the sixth and seventh cervical vertebrae, which are in your neck. Once the nerve is formed, it runs up to enter the cranial cavity ...

The spinal cord travels inside the vertebral column constructed from the front by vertebrae, cushioned by the intervertebral discs, and from the back by the facet joints and lamina. In the cervical ...

Traumatic spinal cord injury is defined as an acute injury of the spinal cord which results in a varying degree of paralysis and/or sensory disorder (1).Injury to the cauda equina is included in the ...

In the spinal cord of control rats, SP (fig 6A, B) and to a minor extent NK-1 (fig 6C, D) labelled nerve processes were seen predominantly in the outermost laminae of the dorsal horn. Conversely, in ...

Tiny, zapping implant gives spinal cord injury survivors new hope UT Dallas researchers paired rehab with vagus nerve stimulation to help people with spinal cord injuries regain arm and hand mobility.

The application space of label-free chemical imaging using coherent Raman scattering (CRS) microscopy in the life sciences and pharma/medical research is expanding rapidly. Ongoing advances in laser ...

Other goals include spinal column stabilization and local ... nerve blocks, corticosteroid therapy, and side effect management, best performed ... Symptoms of Spinal Cord Compression, by Tumor ...

This was followed by labeling of axons and nerve terminals with antibodies against the 165-kDa neurofilament protein (diluted 1:250) and the synaptic vesicle antigen SV2 (diluted 1:500).